| | Term | Count | % | value | Genes |
| | Pathways in cancer | 16 | 61.54 | 3.36E-13 | JUN, SMAD3, CXCL8, STAT1, FOS, EGFR, RELA, VEGFA, IL6, MAPK8, PIK3CA, MYC, AKT1, MAPK1, CTNNB1, and TP53 | | Chagas disease | 14 | 53.85 | 4.42E-18 | JUN, SMAD3, CXCL8, FOS, MAPK14, TNF, IL2, RELA, IL6, MAPK8, PIK3CA, IL1B, AKT1, and MAPK1 | | Hepatitis B | 14 | 53.85 | 3.88E-16 | JUN, CXCL8, STAT1, SRC, FOS, TNF, RELA, IL6, MAPK8, PIK3CA, MYC, AKT1, MAPK1, and TP53 | | Toll-like receptor signaling pathway | 13 | 50.00 | 4.12E-16 | JUN, CXCL8, STAT1, FOS, MAPK14, TNF, RELA, IL6, MAPK8, PIK3CA, IL1B, AKT1, and MAPK1 | | Influenza A | 13 | 50.00 | 1.84E-13 | JUN, CXCL8, STAT1, MAPK14, TNF, RELA, IL6, MAPK8, PIK3CA, IL1B, AKT1, MAPK1, and JAK2 | | Proteoglycans in cancer | 12 | 46.15 | 2.98E-11 | PIK3CA, SRC, MYC, MAPK1, CTNNB1, AKT1, MAPK14, ESR1, TNF, TP53, EGFR, and VEGFA | | MAPK signaling pathway | 12 | 46.15 | 3.79E-10 | JUN, MAPK8, MYC, IL1B, MAPK1, AKT1, FOS, MAPK14, TNF, TP53, RELA, EGFR | | HTLV-I infection | 12 | 46.15 | 3.96E-10 | IL6, JUN, SMAD3, PIK3CA, MYC, CTNNB1, AKT1, FOS, TNF, TP53, RELA, and IL2 | | PI3K-Akt signaling pathway | 12 | 46.15 | 1.02E-08 | IL4, IL6, PIK3CA, MYC, MAPK1, AKT1, JAK2, TP53, RELA, EGFR, IL2, and VEGFA | | Prolactin signaling pathway | 11 | 42.31 | 2.05E-14 | MAPK8, PIK3CA, STAT1, SRC, MAPK1, AKT1, FOS, JAK2, MAPK14, ESR1, and RELA |
|
|
